Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00113100 · ClinicalTrials.gov registry record · NA

Mechanisms of Skin Repair by Topical Estrogen

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
152
Enrollment target

NCT00113100 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 152 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00113100, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
152 participants
Enrollment target

Study Summary

The purpose of this study is to investigate the way by which estrogen improves the appearance of sun damaged human skin. Accumulating evidence suggests that estrogen, taken by post menopausal women, may cause skin to look younger as a consequence of reduced wrinkles. Collagen is the most abundant protein in human skin and gives skin its strength and shape. Recent data indicate that short-term topical estrogen (17-beta estradiol) treatment increases collagen production in sun damaged skin. This study will compare the molecular and microscopic effects from topical 17-beta estradiol (E2) when applied to the skin for a short-term duration. It is anticipated that the new knowledge from this study will enable development of new ways to improve the function of aged skin.

Interventions

  • DRUG Topical 17-beta estradiol in ethanol/propylene glycol (ETOH/PG)

Trial Details

FieldValue
Enrollment Target 152 participants
Start Date 2004-08
Est. Completion 2007-06
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT00113100

The ClinicalTrials.gov registry entry for NCT00113100 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Topical 17-beta estradiol in ethanol/propylene glycol (ETOH/PG) is the first listed.

NCT00113100 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00113100 about?

NCT00113100 is a clinical study titled "Mechanisms of Skin Repair by Topical Estrogen". The purpose of this study is to investigate the way by which estrogen improves the appearance of sun damaged human skin. Accumulating evidence suggests that estrogen, taken by post menopausal women, may cause skin to look younger as a consequence of reduced wrinkles. Collagen is the most abundant pr...

What is the current status of trial NCT00113100?

This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2004-08. Estimated completion is 2007-06.

What interventions are being tested in trial NCT00113100?

The interventions under investigation include: Topical 17-beta estradiol in ethanol/propylene glycol (ETOH/PG) (DRUG).

Who is sponsoring clinical trial NCT00113100?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.